Oculopharyngodistal myopathy is genetically heterogeneous and most cases are distinct from oculopharyngeal muscular dystrophy

Citation
N. Minami et al., Oculopharyngodistal myopathy is genetically heterogeneous and most cases are distinct from oculopharyngeal muscular dystrophy, NEUROMUSC D, 11(8), 2001, pp. 699-702
Citations number
11
Categorie Soggetti
Neurosciences & Behavoir
Journal title
NEUROMUSCULAR DISORDERS
ISSN journal
09608966 → ACNP
Volume
11
Issue
8
Year of publication
2001
Pages
699 - 702
Database
ISI
SICI code
0960-8966(200111)11:8<699:OMIGHA>2.0.ZU;2-5
Abstract
The question whether oculopharyngodistal myopathy (MIM 164310) is a distinc t disease entity or a variant of oculopharyngeal muscular dystrophy (MIM 16 4300) persists. To answer this question, we examined five patients with the clinical characteristics of oculopharyngodistal myopathy for GCG expansion in poly(A)-binding protein nuclear I gene (previously called poly(A)-bindi ng protein 2), the causative gene defect for oculopharyngeal muscular dystr ophy. Only one of our five patients had the significant GCG expansion. Thus , oculopharyngodistal myopathy is a genetically heterogeneous disorder, whi ch includes patients with oculopharyngeal muscular dystrophy but, for the m ost part, is different genetically from oculopharyngeal muscular dystrophy. (C) 2001 Elsevier Science B.V. All rights reserved.